Imatinib Impurity B is a demethylated analog of the parent drug, arising from incomplete alkylation during synthesis. It retains the pyrimidine-2-ylmethylamine core and piperazine linkage but lacks the N-methyl substitution on the aniline moiety, replacing it with a hydrogen. This structural deviation introduces distinct chromatographic and spectroscopic properties, critical for differentiation during analytical profiling. The compound serves as a reference standard for HPLC-based quantification of process-related impurities in Imatinib API batches.
On RequestCC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)N=C(N)N
InChI=1S/C21H28N6O/c1-15-3-8-18(13-19(15)25-21(22)23)24-20(28)17-6-4-16(5-7-17)14-27-11-9-26(2)10-12-27/h3-8,13H,9-12,14H2,1-2H3,(H,24,28)(H4,22,23,25)
AJNIAMJOBVYWFM-UHFFFAOYSA-N